Sequestration of the short and long isoforms of dopamine D2 receptors expressed in Chinese hamster ovary cells

M Itokawa, M Toru, K Ito, H Tsuga, K Kameyama, T Haga, T Arinami and H Hamaguchi

Department of Neuropsychiatry, School of Medicine, Tokyo Medical and Dental University, Japan.

The short (D2S) and long (D2L) isoforms of dopamine D2 receptors were stably expressed in Chinese hamster ovary cells, and dopamine-induced sequestration was examined by measuring the loss of binding of the hydrophilic ligand [3H]sulpiride from the cell surface. Dopamine treatment of Chinese hamster ovary cells expressing D2S for 30 min at 37 degrees caused a 43.8 +/- 3.4% decrease in [3H]sulpiride binding activity measured by incubation of the treated cells with [3H]sulpiride at 4 degrees for 4 hr after the dopamine was washed out. The half-life of the decrease in binding was estimated to be 18.7 +/- 1.6 min, and the concentration of dopamine giving a half-maximal effect (EC50) was estimated to be 180 +/- 90 nM. The decrease was reversible, and the binding activity was recovered by washing out the dopamine and incubating the cells at 37 degrees for 30 min but was not reversible when the cells were incubated at 4 degrees. The binding activity of [3H]spiperone, a hydrophobic ligand, was not affected by the dopamine treatment under the same experimental conditions. These results indicate that approximately one half of the D2S receptors undergo agonist-induced sequestration, probably endocytosis, in a reversible and temperature-dependent manner. Sequestration of D2L receptors was not as apparent as that of D2S receptors; the decrease in [3H]sulpiride binding activity was 21.6 +/- 0.9% and the rate of the decrease was delayed, with a half-life of 33.2 +/- 7.8 min, although effective concentrations of dopamine were similar, with EC50 = 170 +/- 50 nM. A D2S receptor variant containing a missense mutation changing Ser311 in the third intracellular loop to cysteine was found to be sequestered to a significantly lesser extent than with wild-type D2S receptors. This finding was discussed with respect to the report that this variant gene is found more frequently in schizophrenic patients than in control subjects.

Volume 49, Issue 3, pp. 560-566, 03/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				M. F. Lopez-Aranda, M. J. Acevedo, A. Gutierrez, P. Koulen, and Z. U. Khan Role of a G{alpha}i2 protein splice variant in the formation of an intracellular dopamine D2 receptor pool J. Cell Sci., July 1, 2007; 120(13): 2171 - 2178. [Abstract] [Full Text] [PDF]

				T. A. Macey, V. V. Gurevich, and K. A. Neve Preferential Interaction between the Dopamine D2 Receptor and Arrestin2 in Neostriatal Neurons Mol. Pharmacol., December 1, 2004; 66(6): 1635 - 1642. [Abstract] [Full Text] [PDF]

				Y. Namkung and D. R. Sibley Protein Kinase C Mediates Phosphorylation, Desensitization, and Trafficking of the D2 Dopamine Receptor J. Biol. Chem., November 19, 2004; 279(47): 49533 - 49541. [Abstract] [Full Text] [PDF]

				H. Sugiura, K. Iwata, M. Matsuoka, H. Hayashi, T. Takemiya, S. Yasuda, M. Ichikawa, T. Yamauchi, P. Mehlen, T. Haga, et al. Inhibitory Role of Endophilin 3 in Receptor-mediated Endocytosis J. Biol. Chem., May 28, 2004; 279(22): 23343 - 23348. [Abstract] [Full Text] [PDF]

				S. J. Kim, M. Y. Kim, E. J. Lee, Y. S. Ahn, and J.-H. Baik Distinct Regulation of Internalization and Mitogen-Activated Protein Kinase Activation by Two Isoforms of the Dopamine D2 Receptor Mol. Endocrinol., March 1, 2004; 18(3): 640 - 652. [Abstract] [Full Text] [PDF]

				F. Jeanneteau, J. Diaz, P. Sokoloff, and N. Griffon Interactions of GIPC with Dopamine D2, D3 but not D4 Receptors Define a Novel Mode of Regulation of G Protein-coupled Receptors Mol. Biol. Cell, February 1, 2004; 15(2): 696 - 705. [Abstract] [Full Text] [PDF]

				W. Sun, N. Ginovart, F. Ko, P. Seeman, and S. Kapur In Vivo Evidence for Dopamine-Mediated Internalization of D2-Receptors after Amphetamine: Differential Findings with [3H]Raclopride versus [3H]Spiperone Mol. Pharmacol., February 1, 2003; 63(2): 456 - 462. [Abstract] [Full Text] [PDF]

				J. N. Oak, N. Lavine, and H. H. M. Van Tol Dopamine D4 and D2L Receptor Stimulation of the Mitogen-Activated Protein Kinase Pathway Is Dependent on trans-Activation of the Platelet-Derived Growth Factor Receptor Mol. Pharmacol., July 1, 2001; 60(1): 92 - 103. [Abstract] [Full Text]

				S. S. G. Ferguson Evolving Concepts in G Protein-Coupled Receptor Endocytosis: The Role in Receptor Desensitization and Signaling Pharmacol. Rev., March 1, 2001; 53(1): 1 - 24. [Abstract] [Full Text] [PDF]

				P. Seeman and S. Kapur Schizophrenia: More dopamine, more D2 receptors PNAS, July 5, 2000; 97(14): 7673 - 7675. [Full Text] [PDF]

				K. Shiozaki, E. Iseki, H. Uchiyama, Y. Watanabe, T. Haga, K. Kameyama, T. Ikeda, T. Yamamoto, and K. Kosaka Alterations of muscarinic acetylcholine receptor subtypes in diffuse Lewy body disease: relation to Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, August 1, 1999; 67(2): 209 - 213. [Abstract] [Full Text] [PDF]

				S. W. Edwards and L. E. Limbird Role for the Third Intracellular Loop in Cell Surface Stabilization of the alpha 2A-Adrenergic Receptor J. Biol. Chem., June 4, 1999; 274(23): 16331 - 16336. [Abstract] [Full Text] [PDF]

				J. Zhang, S. S. G. Ferguson, L. S. Barak, S. R. Bodduluri, S. A. Laporte, P.-Y. Law, and M. G. Caron Role for G protein-coupled receptor kinase in agonist-specific regulation of µ-opioid receptor responsiveness PNAS, June 9, 1998; 95(12): 7157 - 7162. [Abstract] [Full Text] [PDF]

				J. Zhang, L. S. Barak, K. E. Winkler, M. G. Caron, and S. S. G. Ferguson A Central Role for beta -Arrestins and Clathrin-coated Vesicle-mediated Endocytosis in beta 2-Adrenergic Receptor Resensitization. DIFFERENTIAL REGULATION OF RECEPTOR RESENSITIZATION IN TWO DISTINCT CELL TYPES J. Biol. Chem., October 24, 1997; 272(43): 27005 - 27014. [Abstract] [Full Text] [PDF]

				G. Y. K. Ng, G. Varghese, H. T. Chung, J. Trogadis, P. Seeman, B. F. O'Dowd, and S. R. George Resistance of the Dopamine D2L Receptor to Desensitization Accompanies the Up-Regulation of Receptors on to the Surface of Sf9 Cells Endocrinology, October 1, 1997; 138(10): 4199 - 4206. [Abstract] [Full Text] [PDF]

				K.-M. Kim, K. J. Valenzano, S. R. Robinson, W. D. Yao, L. S. Barak, and M. G. Caron Differential Regulation of the Dopamine D2 and D3 Receptors by G Protein-coupled Receptor Kinases and beta -Arrestins J. Biol. Chem., September 28, 2001; 276(40): 37409 - 37414. [Abstract] [Full Text] [PDF]